4+ hour, 34+ min ago   (92+ words) This June, ten of the life sciences industry’s most respected board members came to New York for Accenture’s second annual Life Sciences Board Forum for something this industr... Ten life sciences board directors on AI's three hardest questions: developing the…...

4+ day, 3+ hour ago   (83+ words) Moonwalk Biosciences' $70 Million Series B | PharmExec Pharmaceutical Executive Aptar Pharma and Aceso Therapeutics team up to advance an inhaled cystic fibrosis therapy, Moonwalk Biosciences raises a $70 million Series B for its fat-targeted obesity platform, and Sebastian Arana of MilliporeSigma talks…...

2+ week, 3+ day ago   (57+ words) Why Global Science Innovation is Shifting to Asia Pharmaceutical Executive Pharmaceutical Executive Daily: FDA Approves Imaavy for wAIHA What Executives and Investors Are Looking for in Pharma Companies FDA Approves Imaavy for Warm Autoimmune Hemolytic Anemia in Patients Aged 12 and…...

3+ week, 1+ day ago   (209+ words) Pharmaceutical Executive Earlier this year, Pharmaceutical Executive reported on China’s growing prominence in the pharma and biotech spaces During this year, billions of dollars have been committed to licensing commitments with Chinese companies, with many US-based companies making up…...

1+ mon, 1+ week ago   (293+ words) Incubate’s executive director discusses China’s rise in biotech and why the US’ best response may be to focus on its own issues. Earlier this year, a report from Pharmaceutical Executive detailed the ways in which China is becoming an essential…...

1+ mon, 1+ week ago   (161+ words) Clinical trials now generate 5.9 million datapoints per Phase III protocol — and most sponsors are still managing them manually. Real-time data (RTD) offers exciting opportunities to empower clinical trial teams with the trusted, actionable insight that is vital for successful and…...

1+ mon, 2+ week ago   (444+ words) TruTechnologies chairman and co-founder argues that while Operation TrialBlazer is directionally correct in targeting regulatory friction, it misses the larger problem. FDA’s latest initiative to improve the drug approval process is Project Trialblazer. The pilot program is designed to accelerate…...

1+ mon, 2+ week ago   (215+ words) TruTechnologies’ Dr. Richard Graham explains where he sees the actual issues that need to be addressed at FDA. FDA’s latest initiative to improve the drug approval process is Project Trialblazer. The pilot program is designed to accelerate early-stage clinical trial....

1+ mon, 3+ week ago   (96+ words) Pharmaceutical Executive What if patient onboarding evolved alongside today's therapies? Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers. The Connected Patient Ecosystem Human Factors is more than a regulatory…...

1+ mon, 4+ week ago   (54+ words) Why we need better drugs_ not just more drugs(1) Pharmaceutical Executive Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration Nuvation Bio’s Approach to Building a Compelling Narrative FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab…...